PAR 5.36% 29.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-137

  1. 46 Posts.
    lightbulb Created with Sketch. 1
    Can anyone give me some ideas, is there another biotech company in ASX got into the Phase 3 trial like us?
    Might give a good indication for the SP, but for the long-term, I am fully confident on PAR.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.